Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.43
-0.24 (-2.48%)
Jul 10, 2026, 12:07 PM EDT - Market open
Cartesian Therapeutics Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed a quorum, elected three directors for terms expiring in 2029, and saw overwhelming approval for executive compensation and auditor ratification, each with 99% support. No questions were raised by stockholders during the Q&A.